{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T17:09:34Z","timestamp":1767978574646,"version":"3.49.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["IK2-CX002195"],"award-info":[{"award-number":["IK2-CX002195"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["IO1-CX001901"],"award-info":[{"award-number":["IO1-CX001901"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["K24DK110427"],"award-info":[{"award-number":["K24DK110427"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL148182"],"award-info":[{"award-number":["R01HL148182"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["U2CDK129496"],"award-info":[{"award-number":["U2CDK129496"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s00467-022-05812-x","type":"journal-article","created":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T14:08:02Z","timestamp":1670854082000},"page":"2179-2187","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Plasma FGF23 is associated with left atrial remodeling in children on hemodialysis"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9011-0163","authenticated-orcid":false,"given":"Shilpa","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nisha R.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark R.","family":"Hanudel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim H.","family":"Ix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isidro B.","family":"Salusky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim-Lien","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,12]]},"reference":[{"key":"5812_CR1","doi-asserted-by":"publisher","first-page":"344","DOI":"10.2215\/CJN.05840513","volume":"9","author":"AA Portale","year":"2014","unstructured":"Portale AA, Wolf M, Juppner H, Messinger S et al (2014) Disordered FGF23 and mineral metabolism in children with CKD. Clin J Am Soc Nephrol 9:344\u2013353. https:\/\/doi.org\/10.2215\/CJN.05840513","journal-title":"Clin J Am Soc Nephrol"},{"key":"5812_CR2","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/ki.2011.47","volume":"79","author":"T Isakova","year":"2011","unstructured":"Isakova T, Wahl P, Vargas GS, Guti\u00e9rrez OM et al (2011) Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int 79:1370\u20131378. https:\/\/doi.org\/10.1038\/ki.2011.47","journal-title":"Kidney Int"},{"key":"5812_CR3","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.bone.2009.08.008","volume":"45","author":"RC Pereira","year":"2009","unstructured":"Pereira RC, Juppner H, Azucena-Serrano CE, Yadin O et al (2009) Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease. Bone 45:1161\u20131168. https:\/\/doi.org\/10.1016\/j.bone.2009.08.008","journal-title":"Bone"},{"key":"5812_CR4","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/ki.2012.176","volume":"82","author":"M Wolf","year":"2012","unstructured":"Wolf M (2012) Update on fibroblast growth factor 23 in chronic kidney disease. Kidney Int 82:737\u2013747. https:\/\/doi.org\/10.1038\/ki.2012.176","journal-title":"Kidney Int"},{"key":"5812_CR5","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.2215\/CJN.04290511","volume":"6","author":"T Isakova","year":"2011","unstructured":"Isakova T, Xie H, Barchi-Chung A, Vargas G et al (2011) Fibroblast growth factor 23 in patients undergoing peritoneal dialysis. Clin J Am Soc Nephrol 6:2688\u20132695. https:\/\/doi.org\/10.2215\/CJN.04290511","journal-title":"Clin J Am Soc Nephrol"},{"key":"5812_CR6","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1093\/ndt\/gfr596","volume":"27","author":"L Viaene","year":"2012","unstructured":"Viaene L, Bammens B, Meijers BK, Vanrenterghem Y et al (2012) Residual renal function is an independent determinant of serum FGF-23 levels in dialysis patients. Nephrol Dial Transplant 27:2017\u20132022. https:\/\/doi.org\/10.1093\/ndt\/gfr596","journal-title":"Nephrol Dial Transplant"},{"key":"5812_CR7","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1093\/ndt\/gft382","volume":"29","author":"J Zaritsky","year":"2014","unstructured":"Zaritsky J, Rastogi A, Fischmann G, Yan J, Kleinman K et al (2014) Short daily hemodialysis is associated with lower plasma FGF23 levels when compared with conventional hemodialysis. Nephrol Dial Transplant 29:437\u2013441. https:\/\/doi.org\/10.1093\/ndt\/gft382","journal-title":"Nephrol Dial Transplant"},{"key":"5812_CR8","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1159\/000465513","volume":"44","author":"N Carlson","year":"2017","unstructured":"Carlson N, Mortensen OH, Axelsen M, Pedersen RS et al (2017) Clearance of sclerostin, osteocalcin, fibroblast growth factor 23, and osteoprotegerin by dialysis. Blood Purif 44:122\u2013128. https:\/\/doi.org\/10.1159\/000465513","journal-title":"Blood Purif"},{"key":"5812_CR9","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1056\/NEJMoa0706130","volume":"359","author":"OM Gutierrez","year":"2008","unstructured":"Gutierrez OM, Mannstadt M, Isakova T, Rauh-Hain JA et al (2008) Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 359:584\u2013592. https:\/\/doi.org\/10.1056\/NEJMoa0706130","journal-title":"N Engl J Med"},{"key":"5812_CR10","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jacc.2012.03.040","volume":"60","author":"JH Ix","year":"2012","unstructured":"Ix JH, Katz R, Kestenbaum BR, de Boer IH et al (2012) Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (cardiovascular health study). J Am Coll Cardiol 60:200\u2013207. https:\/\/doi.org\/10.1016\/j.jacc.2012.03.040","journal-title":"J Am Coll Cardiol"},{"key":"5812_CR11","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2215\/CJN.02110217","volume":"13","author":"MM Mitsnefes","year":"2018","unstructured":"Mitsnefes MM, Betoko A, Schneider MF, Salusky IB et al (2018) FGF23 and left ventricular hypertrophy in children with CKD. Clin J Am Soc Nephrol 13:45\u201352. https:\/\/doi.org\/10.2215\/CJN.02110217","journal-title":"Clin J Am Soc Nephrol"},{"key":"5812_CR12","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.cmet.2015.09.002","volume":"22","author":"A Grabner","year":"2015","unstructured":"Grabner A, Amaral AP, Schramm K, Singh S et al (2015) Activation of cardiac fibroblast growth factor receptor 4 causes left ventricular hypertrophy. Cell Metab 22:1020\u20131032. https:\/\/doi.org\/10.1016\/j.cmet.2015.09.002","journal-title":"Cell Metab"},{"key":"5812_CR13","doi-asserted-by":"publisher","first-page":"64649","DOI":"10.18632\/oncotarget.11623","volume":"7","author":"H Hao","year":"2016","unstructured":"Hao H, Li X, Li Q, Hairuo L et al (2016) FGF23 promotes myocardial fibrosis in mice through activation of beta-catenin. Oncotarget 7:64649\u201364664. https:\/\/doi.org\/10.18632\/oncotarget.11623","journal-title":"Oncotarget"},{"key":"5812_CR14","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1016\/j.jacc.2014.02.555","volume":"63","author":"S Nattel","year":"2014","unstructured":"Nattel S, Harada M (2014) Atrial remodeling and atrial fibrillation: recent advances and translational perspectives. J Am Coll Cardiol 63:2335\u20132345. https:\/\/doi.org\/10.1016\/j.jacc.2014.02.555","journal-title":"J Am Coll Cardiol"},{"key":"5812_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jcmg.2016.11.003","volume":"10","author":"L Thomas","year":"2017","unstructured":"Thomas L, Abhayaratna WP (2017) Left atrial reverse remodeling: mechanisms, evaluation, and clinical significance. JACC Cardiovasc Imaging 10:65\u201377. https:\/\/doi.org\/10.1016\/j.jcmg.2016.11.003","journal-title":"JACC Cardiovasc Imaging"},{"key":"5812_CR16","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1046\/j.1523-1755.2002.00472.x","volume":"62","author":"BM Chavers","year":"2002","unstructured":"Chavers BM, Li S, Collins AJ, Herzog CA (2002) Cardiovascular disease in pediatric chronic dialysis patients. Kidney Int 62:648\u2013653. https:\/\/doi.org\/10.1046\/j.1523-1755.2002.00472.x","journal-title":"Kidney Int"},{"key":"5812_CR17","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1542\/peds.2010-3175","volume":"127","author":"TJ Mathews","year":"2011","unstructured":"Mathews TJ, Minino AM, Osterman MJ, Strobino DM, Guyer B (2011) Annual summary of vital statistics: 2008. Pediatrics 127:146\u2013157. https:\/\/doi.org\/10.1542\/peds.2010-3175","journal-title":"Pediatrics"},{"key":"5812_CR18","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1007\/s00467-016-3362-0","volume":"31","author":"M van Huis","year":"2016","unstructured":"van Huis M, Schoenmaker NJ, Groothoff JW, van der Lee JH et al (2016) Impaired longitudinal deformation measured by speckle-tracking echocardiography in children with end-stage renal disease. Pediatr Nephrol 31:1499\u20131508. https:\/\/doi.org\/10.1007\/s00467-016-3362-0","journal-title":"Pediatr Nephrol"},{"key":"5812_CR19","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/1744-9987.12794","volume":"23","author":"A Gheissari","year":"2019","unstructured":"Gheissari A, Dehghan B, Ghaed Sharafi B, Abedini A et al (2019) Importance of mean platelet volume in predicting cardiac mechanics parameters and carotid-intima media thickness in children with end-stage renal disease and comparison with healthy children. Ther Apher Dial 23:451\u2013459. https:\/\/doi.org\/10.1111\/1744-9987.12794","journal-title":"Ther Apher Dial"},{"key":"5812_CR20","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.echo.2020.03.021","volume":"33","author":"L Thomas","year":"2020","unstructured":"Thomas L, Muraru D, Popescu BA, Sitges M et al (2020) Evaluation of left atrial size and function: relevance for clinical practice. J Am Soc Echocardiogr 33:934\u2013952. https:\/\/doi.org\/10.1016\/j.echo.2020.03.021","journal-title":"J Am Soc Echocardiogr"},{"key":"5812_CR21","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s12574-016-0283-7","volume":"14","author":"S Yuda","year":"2016","unstructured":"Yuda S, Muranaka A, Miura T (2016) Clinical implications of left atrial function assessed by speckle tracking echocardiography. J Echocardiogr 14:104\u2013112. https:\/\/doi.org\/10.1007\/s12574-016-0283-7","journal-title":"J Echocardiogr"},{"key":"5812_CR22","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1136\/heartjnl-2011-300134","volume":"97","author":"AC Boyd","year":"2011","unstructured":"Boyd AC, Richards DA, Marwick T, Thomas L (2011) Atrial strain rate is a sensitive measure of alterations in atrial phasic function in healthy ageing. Heart 97:1513\u20131519. https:\/\/doi.org\/10.1136\/heartjnl-2011-300134","journal-title":"Heart"},{"key":"5812_CR23","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1093\/ehjci\/jeu219","volume":"16","author":"DA Morris","year":"2015","unstructured":"Morris DA, Takeuchi M, Krisper M, K\u00f6hncke C et al (2015) Normal values and clinical relevance of left atrial myocardial function analysed by speckle-tracking echocardiography: multicentre study. Eur Heart J Cardiovasc Imaging 16:364\u2013372. https:\/\/doi.org\/10.1093\/ehjci\/jeu219","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"5812_CR24","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12893-017-0264-4","volume":"17","author":"S Li","year":"2017","unstructured":"Li S, Zhou K, Du H, Shen C, Li Y, Che G (2017) Body surface area is a novel predictor for surgical complications following video-assisted thoracoscopic surgery for lung adenocarcinoma: a retrospective cohort study. BMC Surg 17:69. https:\/\/doi.org\/10.1186\/s12893-017-0264-4","journal-title":"BMC Surg"},{"key":"5812_CR25","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1159\/000497445","volume":"49","author":"A Jovanovich","year":"2019","unstructured":"Jovanovich A, You Z, Isakova T, Nowak K et al (2019) Fibroblast growth factor 23 trajectories in chronic hemodialysis patients: lessons from the HEMO study. Am J Nephrol 49:263\u2013270. https:\/\/doi.org\/10.1159\/000497445","journal-title":"Am J Nephrol"},{"key":"5812_CR26","doi-asserted-by":"publisher","unstructured":"Bouma-de Krijger A, de Roij van Zuijdewijn CLM, Nub\u00e9 MJ, Grooteman MPC et al, CONTRAST Study Group (2020) Change in FGF23 concentration over time and its association with all-cause mortality in patients treated with haemodialysis or haemodiafiltration. Clin Kidney J 14:891-897. https:\/\/doi.org\/10.1093\/ckj\/sfaa028","DOI":"10.1093\/ckj\/sfaa028"},{"key":"5812_CR27","doi-asserted-by":"publisher","unstructured":"Marino PN (2021) Left atrial conduit function: a short review. Physiol Rep 9:e15053. https:\/\/doi.org\/10.14814\/phy2.15053","DOI":"10.14814\/phy2.15053"},{"key":"5812_CR28","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1016\/j.jacc.2006.02.048","volume":"47","author":"WP Abhayaratna","year":"2006","unstructured":"Abhayaratna WP, Seward JB, Appleton CP, Douglas PS et al (2006) Left atrial size: physiologic determinants and clinical applications. J Am Coll Cardiol 47:2357\u20132363. https:\/\/doi.org\/10.1016\/j.jacc.2006.02.048","journal-title":"J Am Coll Cardiol"},{"key":"5812_CR29","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.jacc.2019.11.013","volume":"75","author":"F Bisbal","year":"2020","unstructured":"Bisbal F, Baranchuk A, Braunwald E, Bayes de Luna A, Bayes-Genis A (2020) Atrial failure as a clinical entity: JACC review topic of the week. J Am Coll Cardiol 75:222\u2013232. https:\/\/doi.org\/10.1016\/j.jacc.2019.11.013","journal-title":"J Am Coll Cardiol"},{"key":"5812_CR30","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.04.004","volume":"28","author":"K Meisel","year":"2019","unstructured":"Meisel K, Yuan K, Fang Q, Bibby D, Lee R, Schiller NB (2019) Embolic stroke of undetermined source: a population with left atrial dysfunction. J Stroke Cerebrovasc Dis 28:1891\u20131896. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2019.04.004","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"5812_CR31","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jacc.2006.08.050","volume":"49","author":"V Melenovsky","year":"2007","unstructured":"Melenovsky V, Borlaug BA, Rosen B, Hat I et al (2007) Cardiovascular features of heart failure with preserved ejection fraction versus nonfailing hypertensive left ventricular hypertrophy in the urban Baltimore community: the role of atrial remodeling\/dysfunction. J Am Coll Cardiol 49:198\u2013207. https:\/\/doi.org\/10.1016\/j.jacc.2006.08.050","journal-title":"J Am Coll Cardiol"},{"key":"5812_CR32","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1002\/ejhf.147","volume":"16","author":"AB Santos","year":"2014","unstructured":"Santos AB, Kraigher-Krainer E, Gupta DK, Claggett B et al (2014) Impaired left atrial function in heart failure with preserved ejection fraction. Eur J Heart Fail 16:1096\u20131103. https:\/\/doi.org\/10.1002\/ejhf.147","journal-title":"Eur J Heart Fail"},{"key":"5812_CR33","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/s0735-1097(03)00578-3","volume":"42","author":"C Boixel","year":"2003","unstructured":"Boixel C, Fontaine V, Rucker-Martin C, Milliez P et al (2003) Fibrosis of the left atria during progression of heart failure is associated with increased matrix metalloproteinases in the rat. J Am Coll Cardiol 42:336\u2013344. https:\/\/doi.org\/10.1016\/s0735-1097(03)00578-3","journal-title":"J Am Coll Cardiol"},{"key":"5812_CR34","doi-asserted-by":"publisher","first-page":"H207","DOI":"10.1152\/ajpheart.2001.281.1.H207","volume":"281","author":"SM Dolgilevich","year":"2001","unstructured":"Dolgilevich SM, Siri FM, Atlas SA, Eng C (2001) Changes in collagenase and collagen gene expression after induction of aortocaval fistula in rats. Am J Physiol Heart Circ Physiol 281:H207-214. https:\/\/doi.org\/10.1152\/ajpheart.2001.281.1.H207","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"5812_CR35","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.jacbts.2019.05.005","volume":"4","author":"MJ Shen","year":"2019","unstructured":"Shen MJ, Arora R, Jalife J (2019) Atrial myopathy. JACC Basic Transl Sci 4:640\u2013654. https:\/\/doi.org\/10.1016\/j.jacbts.2019.05.005","journal-title":"JACC Basic Transl Sci"},{"key":"5812_CR36","doi-asserted-by":"publisher","first-page":"341","DOI":"10.5603\/KP.2013.0061","volume":"71","author":"RE Altekin","year":"2013","unstructured":"Altekin RE, Yanikoglu A, Karakas MS, Ozel D, Yilmaz H, Demir I (2013) Evaluation of left atrial function using two-dimensional speckle tracking echocardiography in end-stage renal disease patients with preserved left ventricular ejection fraction. Kardiol Pol 71:341\u2013351. https:\/\/doi.org\/10.5603\/KP.2013.0061","journal-title":"Kardiol Pol"},{"key":"5812_CR37","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1111\/echo.13284","volume":"33","author":"AM Calleja","year":"2016","unstructured":"Calleja AM, Rakowski H, Williams LK, Jamorski M, Chan CT, Carasso S (2016) Left atrial and ventricular systolic and diastolic myocardial mechanics in patients with end-stage renal disease. Echocardiography 33:1495\u20131503. https:\/\/doi.org\/10.1111\/echo.13284","journal-title":"Echocardiography"},{"key":"5812_CR38","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/echo.13101","volume":"33","author":"N Hassanin","year":"2016","unstructured":"Hassanin N, Alkemary A (2016) Detection of left atrium myopathy using two-dimensional speckle tracking echocardiography in patients with end-stage renal disease on dialysis therapy. Echocardiography 33:233\u2013241. https:\/\/doi.org\/10.1111\/echo.13101","journal-title":"Echocardiography"},{"key":"5812_CR39","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1007\/s10554-019-01622-9","volume":"35","author":"C Li","year":"2019","unstructured":"Li C, Zhang J, Fan R, Wei Li et al (2019) Left atrial strain associated with alterations in cardiac diastolic function in patients with end-stage renal disease. Int J Cardiovasc Imaging 35:1803\u20131810. https:\/\/doi.org\/10.1007\/s10554-019-01622-9","journal-title":"Int J Cardiovasc Imaging"},{"key":"5812_CR40","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s12574-016-0276-6","volume":"14","author":"L Abid","year":"2016","unstructured":"Abid L, Charfeddine S, Kammoun S (2016) Relationship of left atrial global peak systolic strain with left ventricular diastolic dysfunction and brain natriuretic peptide level in end-stage renal disease patients with preserved left ventricular ejection fraction. J Echocardiogr 14:71\u201378. https:\/\/doi.org\/10.1007\/s12574-016-0276-6","journal-title":"J Echocardiogr"},{"key":"5812_CR41","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1093\/ehjci\/jes069","volume":"13","author":"CS Park","year":"2012","unstructured":"Park CS, Kim YK, Song HC, Choi EJ et al (2012) Effect of preload on left atrial function: evaluated by tissue Doppler and strain imaging. Eur Heart J Cardiovasc Imaging 13:938\u2013947. https:\/\/doi.org\/10.1093\/ehjci\/jes069","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"5812_CR42","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1007\/s10554-021-02350-9","volume":"37","author":"TT Doan","year":"2021","unstructured":"Doan TT, Srivaths P, Liu A, Wilkes JK et al (2021) Left ventricular strain and left atrial strain are impaired during hemodialysis in children. Int J Cardiovasc Imaging 37:3489\u20133497. https:\/\/doi.org\/10.1007\/s10554-021-02350-9","journal-title":"Int J Cardiovasc Imaging"},{"key":"5812_CR43","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1093\/ndt\/gfy006","volume":"33","author":"M Leifheit-Nestler","year":"2018","unstructured":"Leifheit-Nestler M, Kirchhoff F, Nespor J, Richter B et al (2018) Fibroblast growth factor 23 is induced by an activated renin-angiotensin-aldosterone system in cardiac myocytes and promotes the pro-fibrotic crosstalk between cardiac myocytes and fibroblasts. Nephrol Dial Transplant 33:1722\u20131734. https:\/\/doi.org\/10.1093\/ndt\/gfy006","journal-title":"Nephrol Dial Transplant"},{"key":"5812_CR44","doi-asserted-by":"publisher","first-page":"E863","DOI":"10.1152\/ajpendo.00596.2012","volume":"304","author":"CD Touchberry","year":"2013","unstructured":"Touchberry CD, Green TM, Tchikrizov V, Mannix JE et al (2013) FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophy. Am J Physiol Endocrinol Metab 304:E863-873. https:\/\/doi.org\/10.1152\/ajpendo.00596.2012","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"5812_CR45","doi-asserted-by":"publisher","first-page":"e011925","DOI":"10.1161\/CIRCIMAGING.120.011925","volume":"13","author":"RB Patel","year":"2020","unstructured":"Patel RB, Ning H, de Boer IH, Kestenbaum B et al (2020) Fibroblast growth factor 23 and long-term cardiac function: the multi-ethnic study of atherosclerosis. Circ Cardiovasc Imaging 13:e011925. https:\/\/doi.org\/10.1161\/CIRCIMAGING.120.011925","journal-title":"Circ Cardiovasc Imaging"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-022-05812-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-022-05812-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-022-05812-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T11:05:46Z","timestamp":1685617546000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-022-05812-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,12]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["5812"],"URL":"https:\/\/doi.org\/10.1007\/s00467-022-05812-x","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,12]]},"assertion":[{"value":"6 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Ix is the principal investigator of an investigator-initiated research grant from Baxter International, serves as a data safety monitoring board member for Sanifit International, and has served on advisory boards for Alpha Young, AstraZeneca, Ardelyx Inc., and Jnana Inc. Dr. Salusky has served on advisory boards for Akebia, Inozyme, and Ardelyx. The remaining authors have declared no relevant conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}